Africa’s First CAP-Accredited Central Lab
From complexity to clarity – cost-effective, high-impact clinical trials in Sub-Saharan Africa, powered by the integration of MLM Medical Labs and Cytespace Africa Laboratories
Questions? Speak with our experts
Global Trials. Accelerated in Africa
Reach diverse, treatment-naïve patient populations with faster start-up times, lower recruitment costs and faster enrollment.
With geopolitical changes limiting access to traditional recruitment hubs, sponsors are turning to Africa—an equally rich, underutilized alternative that offers faster enrollment, competitive per-patient costs, large treatment-naïve cohorts, and diverse genomic representation.
Wholly owned by MLM and led and managed by local experts with more than 30 years of regional experience, Cytespace Africa Labs offers:
■ Strategic reach: Trial-ready infrastructure in South Africa with service coverage across 17 African countries.
■ Scientific depth: PhD-led teams with Africa-specific trial expertise.
■ Proven compliance: Africa’s first (and South Africa’s only) CAP-accredited central lab
The Cytespace + MLM Difference:
Unlike outsourced partnerships, Cytespace Africa Labs is locally led and directly managed, ensuring stability, accountability, and deep knowledge of country-specific regulations across the region. Sponsors gain confidence from leadership embedded in Sub-Saharan Africa—supported by the added strength of MLM’s global quality framework.
Infectious Disease Testing Built for This Moment
Enable faster enrollment in infectious disease trials with advanced diagnostics, specialized infrastructure, and proven logistics support.
Infectious diseases remain a key research priority in Africa. Led and managed by local experts with more than 30 years of regional experience, Cytespace Africa Labs delivers rapid, high-quality results within MLM’s global quality framework—supporting faster enrollment and trial success.
Cytespace Africa Labs offers:
■ Two Biosafety Level 3 TB laboratories for complex tuberculosis research.
■ Experienced infectious disease project managers with deep regional expertise.
■ Optimized cold-chain logistics to maintain sample integrity across challenging environments.
The MLM + Cytespace Difference:
MLM is the only global central lab with wholly owned, CAP-accredited operations in Africa, providing a single global database to our labs in Europe and North America and partners in Asia.
Data You Can Trust. Compliance You Can Count On.
Running trials in Africa can bring unique challenges—evolving regulatory landscape and country specific guidelines, and sample handling delays. With Cytespace Africa Labs, sponsors avoid those costly pitfalls.
■ 99% on-time sample turnaround for 48-hour TATs.
■ Expert navigation of complex African regulatory frameworks.
■ Consolidated reporting through MLM’s proprietary global platforms.
■ On-the-ground logistics teams with deep local networks.
The MLM + Cytespace Advantage:
Cytespace Africa Labs is led and managed by local experts who understand regulatory frameworks across the region. Sponsors benefit from streamlined processes and trusted oversight—supported by MLM’s global reporting tools that bring clarity and consistency to multinational trial data.
Scale Confidently Across Continents
Move from preclinical to Phase IV with one global partner.
■ Currently serving nearly 400 clinical trials, including global Phase 3 and multi-country programs.
■ Broad therapeutic expertise: oncology, infectious diseases, neurodegeneration, NCDs, and more.
■ Trusted partner for customized kit building, biomarker analysis, histology, and global logistics support.
■ >85% repeat clients among Sponors & CROs.
The MLM Advantage:
MLM is laser-focused on supporting clinical trials—a global laboratory powerhouse with CRO-level agility, wholly owned facilities in Africa, and proven Phase I – IV trial execution worldwide
Connect With MLM Medical Labs Today
Expedite your new therapies for patients worldwide using quality clinical lab testing from MLM Medical Labs. Request a proposal or contact us for more information today.
